2016 International Congress Archives - Page 34 of 207

12:00pm-1:30pm: Neuro-cognitive domain related to conversion of Parkinson’s disease dementia

S.M. Cheon, S.Y. Lee, J.W. Kim (Busan, Korea)

Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neuroanatomical correlates of apathy in non-demented and non-depressed Parkinson’s disease

S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Marin-Lahoz, J. Kulisevsky (Barcelona, Spain)

Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neuroleptic medication is associated with a worse health status in the years prior to treatment, but have the potential for normalization

P. Schmidt, F. Cubillos, T. Simuni, C. Marras, T. Davis, E.C. Nelson, M.S. Okun (Miami, FL, USA)

Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neurologic phenotipic variability in spinocerebelar ataxia hype 2 (SCA2)

T.L. Monte, C.L. Lucas, S. Amanda, R. Estela, A. Marina, M.L.S. Pereira, J.L. Pedroso, O. Barsotini, F.R. Vargas, P. Fernanda, R. Castilho, L.B. Jardim (Porto Alegre, Brazil)

Ataxia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neuromelanin in Parkinson’s disease: A 3 T MRI study

S. Pietracupa, A. Martin-Bastida, N.L. Kaim, S. Schwarz, D. Auer, A. Berardelli, P. Piccini (Rome, Italy)

Imaging and Neurophysiology

12:00pm-1:30pm: Neuromelanin-MRI of substantia nigra subregions in Parkinson’s disease

L. Borellini, G. Franco, P. Trujillo, P. Summers, A. Di Fonzo, D.O. Claassen, A. Costa (Milan, Italy)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neuron specific protein S100B and cognitive impairment in various forms parkinsonism

R.J. Matmurodov, K.M. Khalimova, N.S. Rashidova, U. Ergashev, O. Turgunhojayev (Tashkent, Uzbekistan)

Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neurophysiological evidence of posterior-cortical alterations in premanifest Huntington’s: An event-related brain potentials study of face and face-like objects processing

S. Martinez-Horta, J. Perez-Perez, A. Horta-Barba, R. Fernandez-Bobadilla, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Huntington's disease · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neuroprotective potential of L-theanine against excitotoxic neuronal death induced by quinolinic acid: Possible neurotransmitters and nitric oxide modulation mechanism

S. Jamwal, P. Kumar (Moga, India)

Huntington's disease · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Neuropsychiatric, personality and non-motor correlates of impulse control disorders in recent onset Parkinson’s disease

D.M.A. Swallow, M.A. Lawton, K.A. Grosset, N. Malek, N. Bajaj, R.A. Barker, Y. Ben-Shlomo, D.J. Burn, T. Foltynie, J. Hardy, H.R. Morris, N. Williams, N.W. Wood, D.G. Grosset, PRoBaND Collaborators (Glasgow, United Kingdom)

Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2